News and Insights
Navigating Emerging Markets – Southeast Asia

Southeast Asia is a growing pharmaceutical market. Much like Latin America, the countries of southeast Asia, especially the members of the Association of Southeast Asian Nations (ASEAN: Brunei, Burma, Cambodia, Indonesia, Laos, Malaysia, the Philippines, Singapore, Thailand, and Vietnam), have taken initial steps towards seeking more harmonized regulation of pharmaceutical and medical device industries. However, there are still significant differences in how these markets are regulated today, and these countries vary widely in their stage of development.
Read MoreThank you for your interest in our content. Registering allows you to access a wide range of informative articles, briefs, and whitepapers throughout the site.
Privacy is important. We do not share registrant information with anyone outside of Numerof & Associates. For details, please see our Privacy Policy. Subscribers to our mailings can unsubscribe instantly at any time.
×